---
schema_version: "secwatch.filing_event.v1"
accession: "0001654954-23-008031"
form_type: "8-K"
ticker: "PBSV"
cik: "0001304161"
company_name: "Pharma-Bio Serv, Inc."
filed_at: "2023-06-14T23:59:59+00:00"
generated_at: "2026-06-14T00:57:43.488328+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.55
calibrated_materiality_score: 0.55
confidence: "high"
source: SEC EDGAR
---

# Pharma-Bio Serv Q2 net income rises to $0.4M; revenue falls 8% to $4.6M

## Summary
- Revenue for three months ended Apr 30, 2023: $4.6M, down $0.4M YoY.
- Net income for Q2 was $0.4M, up $0.2M from prior year; H1 net income $0.8M, up $0.3M.
- Gross profit margin improved 5.0 percentage points in Q2 and 4.8 ppts in H1.
- CEO cites strategy to focus on most profitable markets and grow presence.

## SEC filing metadata
- accession: 0001654954-23-008031
- form_type: 8-K
- ticker: PBSV
- cik: 0001304161
- company_name: Pharma-Bio Serv, Inc.
- filed_at: 2023-06-14T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.55
- calibrated_materiality_score: 0.55
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1304161/000165495423008031/0001654954-23-008031-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1304161/000165495423008031/pbsv_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001654954-23-008031
- JSON: https://secwatch.observer/filing/0001654954-23-008031.json
- Plain text: https://secwatch.observer/filing/0001654954-23-008031.txt

## Key facts
- Earnings Releases
  Pharma-Bio Serv, Inc. reported the three and six months ended April 30, 2023 results: revenue approximately $4.6 and $8.8 million, respectively, net income approximately $0.4 and $0.8 million, respectively.
  - Period: the three and six months ended April 30, 2023
  - Revenue: approximately $4.6 and $8.8 million, respectively
  - Net income: approximately $0.4 and $0.8 million, respectively
  - Result: reported results
  source text: revenues for the three and six months ended April 30, 2023 were approximately $4.6 and $8.8 million, respectively, a decrease of approximately $0.4 and $1.2 million, respectively, when compared to the same periods last year.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1304161/000165495423008031/0001654954-23-008031-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.